[Complication of liver cirrhosis and the counter measures].
Abei
T
T
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections; D002511:Cephalosporins / Q000627:therapeutic use; D006801:Humans; D007728:Kupffer Cells / Q000276:immunology; D008103:Liver Cirrhosis / Q000150:complications* / Q000276:immunology; D010538:Peritonitis / Q000209:etiology / Q000382:microbiology / Q000628:therapy; D014395:Peritonitis, Tuberculous / Q000209:etiology; D010587:Phagocytosis; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins